Dermata Therapeutics Inc.

DRMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.15

$0 (0.00%)

At close: Sep 22, 2026, 4:00 PM ET

$1.22

+$0.07 (+6.09%)

After-hours: Sep 22, 2026, 7:42 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Sep 1, 2026

21.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $783.79K

1D Range

1.14 1.17

52W Range

0.95 5.87

Valuation (TTM)

PE -0.26

PB 0.22

EV/EBITDA 0.43

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $6

Cash Flow

FCF Yield -1039.2%

SBC Adj. FCF Yield -1049.3%

SBC Impact -1.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 116.6% | 84.0%

FCF 3Y | 5Y -2.2% | -2.8%

Returns

ROA -157.3%

ROE -166.7%

ROIC -246.6%

Financial Health

Net Cash

$4.41M

Current Ratio 2.81

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer ski...

Sector Healthcare

Industry Biotechnology

Employees 9

IPO Date Aug 12, 2021

Website www.dermatarx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 18, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞